PM Bennett said to have had personal talks with Pfizer CEO Albert Bourla to secure deal, though no decision has yet been made on widespread booster doses

Research was conducted before Delta variant, but deputy head of Sheba Medical Center, which took part in effort, calls findings 'convincing illustration of vaccine effectiveness’

Report indicates more than 60% of those hospitalized with coronavirus are fully vaccinated, but almost all are over age 60

Pfizer says trial results for those aged 5-11 likely in by September; company seeking full approval, as some are hesitant due to emergency use authorization

Rachel and Yitzhak Na'eh, both in their mid-80s, succumb to virus, after suffering from pre-existing conditions as well; become week's 3rd and 4th vaccinated patients to die

Biden administration's chief medical adviser Fauci admits there may be a need for third shot, but hesitant to draw quick conclusions

Israel moving ahead with issuing 3rd dose to the immunocompromised; CDC and FDA say extra vaccine unnecessary 'at this time'

PM says vaccination of ages 12-15 can keep going uninterrupted, with new shots to arrive as existing supplies expire; report says Pfizer shipment will contain 200,000 doses

Most of the vaccinated people who have been recently infected got the shot around January, figures given to Health Ministry show; some caution it's too early to draw conclusions

Health Ministry chief says he hopes there'll be a new Pfizer shipment next month, allowing inoculation campaign to continue; expresses satisfaction at number of teens now immune